4747.TWO · JCP
Taiwan · RS rating 10 · As of 2026-10-08
| Price | 23.35 TWD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 13 / 38 / 8 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 17 / 9 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -83.9% |
| Sales growth Q/Q | -0.0% |
| Distance from 52-week high | +37.7% |
| Market cap (USD) | $65.3M |